Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.44 |
| ▸ | DRD1 | P21728 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8038936 | 0.89 | TDP1 (0.44) | TSHRDRD1MEN1NPC1KMT2A | |
| SCHEMBL4127840 | 0.88 | ALDH1A1 (0.47) | TSHRTP53MEN1NPC1POLB | |
| SCHEMBL472319 | 0.84 | TSHR (0.55) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL18360379 | 0.83 | MAPT (0.53) | MEN1NPC1POLBKMT2AALDH1A1 | |
| SCHEMBL13645018 | 0.80 | CA2 (0.46) | CA1CA2CA12CA3TYR | |
| SCHEMBL202173 | 0.79 | TDP1 (0.50) | TSHRMEN1NPC1POLBKMT2A | |
| SCHEMBL3763384 | 0.79 | NPC1 (0.50) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL2806419 | 0.79 | TSHR (0.48) | TSHRTP53SRD5A2CA1CA2 | |
| SCHEMBL653865 | 0.79 | TSHR (0.52) | TSHRCA1CA2CA12CA7 | |
| SCHEMBL7631517 | 0.79 | AKT1 (0.52) | TP53MEN1NPC1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | claimed |
| US-8822390-B2 | Scale inhibitor | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-09-02 | — | — | US | claimed |
| EP-2556130-A1 | SCALE INHIBITOR | Clariant Finance (BVI) Limited (VG) | 2013-02-13 | — | — | EP | claimed |
| EP-2371923-B1 | Scale inhibitor | CLARIANT FINANCE BVI LTD (VG) | 2013-02-13 | — | — | EP | claimed |
| US-20130023449-A1 | Scale Inhibitor | CLARIANT FINANCE (BVI) LIMITED (VG) | 2013-01-24 | — | — | US | claimed |
| WO-2011120655-A1 | SCALE INHIBITOR | CLARIANT INTERNATIONAL LTD (CH) | 2011-10-06 | — | — | WO | claimed |
| EP-2371923-A1 | Scale inhibitor | Clariant International Ltd. (CH) | 2011-10-05 | — | — | EP | claimed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | claimed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | claimed |
| EP-1975707-B1 | Curable composition and planographic printing plate precursor | FUJIFILM CORP (JP) | 2017-07-19 | — | — | EP | disclosed |
| EP-1801651-B1 | Polymerizable composition and planographic printing plate precursor using the same | FUJIFILM CORP (JP) | 2017-04-19 | — | — | EP | disclosed |
| EP-2471655-B1 | Lithographic printing plate precursor and lithographic printing method | FUJIFILM CORP (JP) | 2016-08-17 | — | — | EP | disclosed |
| EP-1887423-B1 | Laser-decomposable resin composition and pattern-forming material using the same | FUJIFILM CORP (JP) | 2016-01-27 | — | — | EP | disclosed |
| EP-1431032-B1 | Polymerizable composition and lithographic printing plate precursor | FUJIFILM CORP (JP) | 2015-12-09 | — | — | EP | disclosed |
| EP-0618346-B1 | Placing a scale inhibitor within a brine-containing subterranean formation | SHELL INT RESEARCH (NL) | 1997-07-23 | — | — | EP | disclosed |
| US-5629354-A | Photopolymerization initiator system comprising a spectral sensitizer and a polycarboxylic acid co-initiator | EASTMAN KODAK COMPANY (US) | 1997-05-13 | — | — | US | disclosed |
| EP-0765913-A1 | Process for the preparation of lactic acid-based polyester compositions | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1997-04-02 | — | — | EP | disclosed |
| EP-0730201-A1 | Sensitized photopolymerizable compositions and use thereof in lithographic printing plates | EASTMAN KODAK COMPANY (US) | 1996-09-04 | — | — | EP | disclosed |
| EP-0618346-A2 | Placing a scale inhibitor within a brine-containing subterranean formation | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1994-10-05 | — | — | EP | disclosed |
| US-5346010-A | Precipitation of scale inhibitors in subterranean formations | SHELL OIL COMPANY (US) | 1994-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | CUTA, SUCLG1, KRT18 | TSHR 4385/4885TP53 964/4885SRD5A2 919/4885 |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | ACMSD, CUTA, PCCA | TSHR 2885/4885TP53 1009/4885SRD5A2 343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.